Ovid Therapeutics Inc. · NASDAQ:OVID

Affinity Asset Advisors, LLC reported a 9.10% stake in Ovid Therapeutics Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 14, 2026

Affinity Asset Advisors, LLC reported a 9.10% stake in Ovid Therapeutics Inc., 15,635,484 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).

Stake
9.10%
Shares
15,635,484
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC9.10%15,635,484
Michael Cho9.10%15,635,484

Source

View original at SEC

Related